Cutaneous Lymphocyte Antigen (CLA) is a potential therapeutic target in Cutaneous T Cell Lymphoma. Peru S, Prochazkova-Carlotti M, Cherrier F, Velazquez J, et al. J Invest Dermatol 2022 Jul 15. pii: S0022-202X(22)01668.

Read + Share

Amedeo Smart

Independent Medical Education

Peru S, Prochazkova-Carlotti M, Cherrier F, Velazquez J, et al. Cutaneous Lymphocyte Antigen (CLA) is a potential therapeutic target in Cutaneous T Cell Lymphoma. J Invest Dermatol 2022 Jul 15. pii: S0022-202X(22)01668.
PMID: 35850209